Seelos Therapeutics to Participate in 43rd Annual Cowen Health Care Conference

Rhea-AI Summary

Seelos Therapeutics, Inc. (NASDAQ: SEEL) announced its participation in the 43rd Annual Cowen Health Care Conference happening in Boston, Massachusetts from March 6-8, 2023. CEO Raj Mehra and senior management will host meetings during the event. Seelos is focused on developing therapies for central nervous system disorders and rare diseases, with a portfolio targeting conditions like Acute Suicidal Ideation in Major Depressive Disorder and various neurodegenerative diseases including ALS and Huntington’s disease. For more details, visit their website.

NEW YORK, Feb. 15, 2023 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced that it will participate in the 43rd Annual Cowen Health Care Conference, to be held in Boston, Massachusetts on March 6-8th, 2023. 

Raj Mehra Ph.D., Chairman and CEO of Seelos and members of senior management will host one of one meetings at this year's conference. 

More information about the 43rd Annual Cowen Health Care Conference may be accessed here. 

About Seelos Therapeutics:

Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and advancement of novel therapeutics to address unmet medical needs for the benefit of patients with central nervous system (CNS) disorders and other rare diseases. The Company's robust portfolio includes several late-stage clinical assets targeting indications including Acute Suicidal Ideation and Behavior (ASIB) in Major Depressive Disorder (MDD) or Post-Traumatic Stress Disorder (PTSD), amyotrophic lateral sclerosis (ALS), Spinocerebellar ataxia (SCA), Huntington's disease, Parkinson's Disease, other psychiatric and movement disorders plus orphan diseases.

For more information, please visit our website: http://seelostherapeutics.com, the content of which is not incorporated herein by reference.

Contact Information:

Anthony Marciano
Chief Communications Officer 
Seelos Therapeutics, Inc. (Nasdaq: SEEL)
300 Park Ave., 2nd Floor 
New York, NY 10022
(646) 293-2136
anthony.marciano@seelostx.com
https://seelostherapeutics.com/
https://twitter.com/seelostx
https://www.linkedin.com/company/seelos

Mike Moyer
Managing Director
LifeSci Advisors, LLC
250 West 55th St., Suite 3401 
New York, NY 10019
(617) 308-4306
mmoyer@lifesciadvisors.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/seelos-therapeutics-to-participate-in-43rd-annual-cowen-health-care-conference-301747634.html

SOURCE Seelos Therapeutics, Inc.

FAQ

When will Seelos Therapeutics participate in the Cowen Health Care Conference?

Seelos Therapeutics will participate in the 43rd Annual Cowen Health Care Conference from March 6-8, 2023.

Who will represent Seelos Therapeutics at the conference?

Raj Mehra, Ph.D., the CEO, along with senior management, will represent Seelos Therapeutics at the conference.

What is the focus of Seelos Therapeutics?

Seelos Therapeutics is focused on developing therapies for central nervous system disorders and rare diseases.

What are some diseases targeted by Seelos Therapeutics?

Seelos targets diseases such as Major Depressive Disorder, Alzheimer's Disease, and Parkinson's Disease.

Where can I find more information about Seelos Therapeutics?

More information about Seelos Therapeutics can be found on their official website at http://seelostherapeutics.com.